Company page
Humacyte, Inc.
Humacyte, Inc. is a public company traded under the ticker HUMA in the American market. The company has a market capitalization of approximately $249.25 million. Humacyte focuses on developing innovative technologies in the field of regenerative medicine.
- Ticker
- HUMA:NASDAQ
- Asset type
- Stock
- Market cap
- $249.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD